Prevalence and Symptomatic Burden of Diagnosed Endometriosis in the United States: National Estimates from a Cross-Sectional Survey of 59,411 Women
- PMID: 27820938
- DOI: 10.1159/000452660
Prevalence and Symptomatic Burden of Diagnosed Endometriosis in the United States: National Estimates from a Cross-Sectional Survey of 59,411 Women
Abstract
Background/aims: To estimate the prevalence of diagnosed endometriosis (DE) in women in the United States and assess the associated symptomatic burden.
Methods: An online, cross-sectional survey of women aged 18-49 years was conducted from August 6, 2012, through November 14, 2012. Survey data (weighted by age, race, education, income, geographical distribution, and propensity score) were used to estimate the prevalence and symptomatic burden of DE in women in the United States. Weighted logistic regressions were used to assess differences in symptom burden between women with and without endometriosis.
Results: The prevalence of DE was estimated at 6.1% (2,922 of 48,020 women surveyed); 52.7% of women were 18-29 years of age when they were diagnosed with endometriosis. Most (86.2%) women experienced symptoms before diagnosis. More women with (vs. without) DE had menstrual pelvic pain/cramping (52.7 vs. 45.2%), non-menstrual pelvic pain/cramping (36.7 vs. 14.3%), infertility (11.6 vs. 3.4%), and dyspareunia (29.5 vs. 13.4%). Women with endometriosis were also more likely to report severe symptoms (OR (95% CI) 2.7 (2.3-3.1) for menstrual pelvic pain/cramping, 2.2 (1.7-2.9) for non-menstrual pelvic pain/cramping, and 2.4 (1.8-3.2) for dyspareunia).
Conclusion: The prevalence of DE among US women is notable, and affected women experience a substantial symptom burden.
Keywords: Cross-sectional survey; Endometriosis; Prevalence; Symptoms.
© 2016 S. Karger AG, Basel.
Similar articles
-
Prevalence, Symptomatic Burden, and Diagnosis of Endometriosis in Canada: Cross-Sectional Survey of 30 000 Women.J Obstet Gynaecol Can. 2020 Jul;42(7):829-838. doi: 10.1016/j.jogc.2019.10.038. Epub 2020 Jan 27. J Obstet Gynaecol Can. 2020. PMID: 32001176
-
Endometriosis and associated symptoms among Nigerian women.Int J Gynaecol Obstet. 2015 Aug;130(2):190-4. doi: 10.1016/j.ijgo.2015.02.030. Epub 2015 Apr 24. Int J Gynaecol Obstet. 2015. PMID: 25935474
-
The burden of endometriosis symptoms on health-related quality of life in women in the United States: a cross-sectional study.J Psychosom Obstet Gynaecol. 2017 Dec;38(4):238-248. doi: 10.1080/0167482X.2017.1289512. Epub 2017 Feb 21. J Psychosom Obstet Gynaecol. 2017. PMID: 28635533
-
Prevalence of endometriosis diagnosed by laparoscopy in adolescents with dysmenorrhea or chronic pelvic pain: a systematic review.Hum Reprod Update. 2013 Sep-Oct;19(5):570-82. doi: 10.1093/humupd/dmt016. Epub 2013 May 31. Hum Reprod Update. 2013. PMID: 23727940 Review.
-
[Endometriosis : An often unrecognized pain disorder].Schmerz. 2016 Oct;30(5):477-490. doi: 10.1007/s00482-016-0154-1. Schmerz. 2016. PMID: 27681777 Review. German.
Cited by
-
Development of a prediction model to aid primary care physicians in early identification of women at high risk of developing endometriosis: cross-sectional study.BMJ Open. 2019 Dec 4;9(12):e030346. doi: 10.1136/bmjopen-2019-030346. BMJ Open. 2019. PMID: 31806607 Free PMC article.
-
Endometriosis Is Undervalued: A Call to Action.Front Glob Womens Health. 2022 May 10;3:902371. doi: 10.3389/fgwh.2022.902371. eCollection 2022. Front Glob Womens Health. 2022. PMID: 35620300 Free PMC article.
-
Dienogest and the Risk of Reoperation in Endometriosis.J Pers Med. 2021 Sep 17;11(9):924. doi: 10.3390/jpm11090924. J Pers Med. 2021. PMID: 34575701 Free PMC article.
-
Psychometric assessment of the PROMIS Fatigue Short Form 6a in women with moderate-to-severe endometriosis-associated pain.J Patient Rep Outcomes. 2020 Oct 27;4(1):86. doi: 10.1186/s41687-020-00257-y. J Patient Rep Outcomes. 2020. PMID: 33108543 Free PMC article.
-
Quality of Life in Japanese Patients with Dysmenorrhea or Endometriosis-Associated Pelvic Pain Treated with Extended Regimen Ethinylestradiol/Drospirenone in a Real-World Setting: A Prospective Observational Study.Adv Ther. 2022 Nov;39(11):5087-5104. doi: 10.1007/s12325-022-02301-3. Epub 2022 Sep 2. Adv Ther. 2022. PMID: 36053449 Free PMC article.
MeSH terms
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical